Cerus (CERS) Net Cash Flow Growth (3y) (2013 - 2026)
Cerus (CERS) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -48.90% |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 44.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.06% |
| Dec 31, 2025 | -14.59% |
| Sep 30, 2025 | 55.83% |
| Jun 30, 2025 | 13.28% |
| Mar 31, 2025 | 54.75% |
| Dec 31, 2024 | 62.02% |
| Sep 30, 2024 | -23.17% |
| Jun 30, 2024 | -101.15% |
| Mar 31, 2024 | -25.20% |
| Dec 31, 2023 | -41.41% |
| Sep 30, 2023 | 20.94% |
| Jun 30, 2023 | -100.58% |
| Mar 31, 2023 | -83.76% |
| Dec 31, 2022 | -17.06% |
| Sep 30, 2022 | -76.16% |
| Jun 30, 2022 | -0.67% |
| Mar 31, 2022 | -323.91% |
| Dec 31, 2021 | -86.66% |
| Sep 30, 2021 | 34.98% |
| Jun 30, 2021 | 58.96% |